Education
About Us
Working with TipRanks
Follow Us
INNO-GENE Spolka Akcyjna (DE:WQ3)
FRANKFURT:WQ3
Total Valuation
INNO-GENE Spolka Akcyjna has a market cap or net worth of €18.48M. The enterprise value is ―.
Market Cap€18.48M
Enterprise Value―
Share Statistics
INNO-GENE Spolka Akcyjna has 33,581,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,581,080
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
INNO-GENE Spolka Akcyjna’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count15
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of INNO-GENE Spolka Akcyjna is 145.8. INNO-GENE Spolka Akcyjna’s PEG ratio is ―.
PE Ratio145.8
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, INNO-GENE Spolka Akcyjna had revenue of ― and earned 6.14M in profits. Earnings per share was ―.
Revenue―
Gross Profit22.39M
Operating Income9.60M
Pretax Income―
Net Income6.14M
EBITDA9.57M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
INNO-GENE Spolka Akcyjna pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change-19.19%
50-Day Moving Average0.38
200-Day Moving Average0.40
Relative Strength Index (RSI)43.61
Average Volume (3m)0.00
Important Dates
INNO-GENE Spolka Akcyjna upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
INNO-GENE Spolka Akcyjna as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, INNO-GENE Spolka Akcyjna has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
INNO-GENE Spolka Akcyjna EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
INNO-GENE Spolka Akcyjna has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for INNO-GENE Spolka Akcyjna is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―